Brokerages forecast that NCS Multistage Holdings Inc (NASDAQ:NCSM) will post $59.36 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for NCS Multistage’s earnings, with the highest sales estimate coming in at $62.00 million and the lowest estimate coming in at $54.20 million. NCS Multistage reported sales of $62.69 million in the same quarter last year, which would suggest a negative year over year growth rate of 5.3%. The company is scheduled to report its next earnings results on Tuesday, November 5th.

According to Zacks, analysts expect that NCS Multistage will report full-year sales of $204.99 million for the current financial year, with estimates ranging from $200.22 million to $207.95 million. For the next fiscal year, analysts forecast that the business will report sales of $236.37 million, with estimates ranging from $219.34 million to $255.04 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover NCS Multistage.

NCS Multistage (NASDAQ:NCSM) last posted its quarterly earnings results on Monday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.08. The company had revenue of $39.77 million for the quarter, compared to analyst estimates of $37.83 million. NCS Multistage had a negative return on equity of 1.95% and a negative net margin of 112.66%.

Several equities research analysts have recently weighed in on the company. ValuEngine raised NCS Multistage from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $3.00 price target (down from $6.00) on shares of NCS Multistage in a report on Wednesday, August 7th. Piper Jaffray Companies lowered shares of NCS Multistage from an “overweight” rating to a “neutral” rating and set a $3.80 price target on the stock. in a research note on Tuesday, June 25th. Finally, Zacks Investment Research raised shares of NCS Multistage from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $6.66.

Shares of NASDAQ:NCSM traded up $0.03 on Friday, hitting $2.43. 30,317 shares of the company’s stock were exchanged, compared to its average volume of 96,317. NCS Multistage has a 1-year low of $1.56 and a 1-year high of $16.95. The company has a market capitalization of $106.20 million, a PE ratio of 12.15 and a beta of 2.68. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.78 and a current ratio of 4.53. The firm’s 50-day moving average is $2.40 and its 200 day moving average is $3.58.

In other news, Director Franklin Myers purchased 15,000 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were bought at an average price of $2.15 per share, with a total value of $32,250.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have purchased a total of 105,000 shares of company stock worth $220,950 in the last 90 days. 11.90% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of NCSM. Susquehanna International Group LLP purchased a new position in shares of NCS Multistage during the second quarter worth approximately $60,000. Outlook Wealth Advisors LLC purchased a new stake in NCS Multistage in the 2nd quarter valued at $37,000. Citadel Advisors LLC boosted its stake in NCS Multistage by 123.1% during the 2nd quarter. Citadel Advisors LLC now owns 102,655 shares of the company’s stock worth $364,000 after purchasing an additional 56,646 shares during the period. Balyasny Asset Management LLC boosted its stake in NCS Multistage by 122.9% during the 2nd quarter. Balyasny Asset Management LLC now owns 254,395 shares of the company’s stock worth $903,000 after purchasing an additional 140,278 shares during the period. Finally, BlackRock Inc. grew its position in NCS Multistage by 16.9% during the 2nd quarter. BlackRock Inc. now owns 683,328 shares of the company’s stock worth $2,425,000 after purchasing an additional 98,884 shares during the last quarter. Institutional investors own 88.77% of the company’s stock.

NCS Multistage Company Profile

NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.

See Also: What is the CBOE Russell 2000® Volatility Index?

Get a free copy of the Zacks research report on NCS Multistage (NCSM)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for NCS Multistage (NASDAQ:NCSM)

Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with's FREE daily email newsletter.